| Drug Name: | Pivampicillin (33817-20-8) |
|---|---|
| PubChem ID: | 33478 |
| SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)OCOC(=O)C(C)(C)C)C |
| InchiKey: | ZEMIJUDPLILVNQ-ZXFNITATSA-N |
| Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents |
| Molecular Weight (dalton) | : | 463.556 |
| LogP | : | 1.3235 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 128.03 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Valproic Acid (99-66-1) | Increased Risk Of Carnitine Deficiency | Antagonistic | Not fully understood | Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Systemic Carnitine Deficiency | MetaADEDB |